SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 18.04 |
| Enterprise Value ($M) | 82.09 |
| Book Value ($M) | -85.63 |
| Book Value / Share | -1.73 |
| Price / Book | -0.21 |
| NCAV ($M) | -86.73 |
| NCAV / Share | -1.75 |
| Price / NCAV | -0.21 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -3.67 |
| Return on Assets (ROA) | -0.96 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.81 |
| Current Ratio | 1.87 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 47.79 |
| Assets | 48.89 |
| Liabilities | 134.53 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| SCHEDULE 13G | Oaktree Capital Group Holdings GP, LLC | |||
| SCHEDULE 13G | Qatar Investment Authority | |||
| 13G/A | Fmr Llc | 2.64 | -57.30 | |
| 13D/A | Bioxcel Corp | 23.50 | -7.09 | |
| 13G/A | Adage Capital Partners Gp, L.l.c. | 1.55 | -69.95 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 396,448 | 1,054,266 | 37.60 | |
| 1,130,379 | 3,086,437 | 36.62 | |
| 273,697 | 689,643 | 39.69 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| BOLT – Bolt Biotherapeutics, Inc. | BON – Bon Natural Life Limited |
| BPTH – Bio-Path Holdings, Inc. | BYSI – BeyondSpring Inc. |
| CALC – CalciMedica, Inc. |
Financial data and stock pages provided by
Fintel.io